NCT00491608View on ClinicalTrials.gov

Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis

PHASE3CompletedINTERVENTIONAL
Enrollment

234

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Spinal SurgeryVascular Surgery
Interventions
BIOLOGICAL

rThrombin

1000 U/mL applied directly or in combination with absorbable gelatin sponge or powder

Trial Locations (1)

91105

Huntington Memorial Hospital, Pasadena

Sponsors

Lead Sponsor

ZymoGenetics
All Listed Sponsors
lead

ZymoGenetics

INDUSTRY

NCT00491608 - Immunogenicity and Safety Study of Topical Recombinant Thrombin in Surgical Hemostasis | Biotech Hunter | Biotech Hunter